| 000 | 01034 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512021637.0 | ||
| 264 | 0 | _c19871230 | |
| 008 | 198712s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/20.4.612 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillespie, S H | |
| 245 | 0 | 0 |
_aIn-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cOct 1987 |
||
| 300 |
_a612-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelioidosis _xdrug therapy |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPseudomonas _xdrug effects |
| 650 | 0 | 4 | _aTopoisomerase II Inhibitors |
| 700 | 1 | _aMcEniry, D W | |
| 700 | 1 | _aFelmingham, D | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 20 _gno. 4 _gp. 612-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/20.4.612 _zAvailable from publisher's website |
| 999 |
_c2830293 _d2830293 |
||